Amarex Clinical
Trial Micro-site

Designed and developed a clinical trial micro-site for Amarex Clinical Research on behalf of CytoDyn, a biotechnology company whose medical products target HIV and cancer treatments. This clinical trial site focused on individuals diagnosed with Triple-Negative Breast Cancer and the medical drug Leronlimab (PRO 140), an investigational drug designed to help prevent the spread of cancer cells in the body. The micro-site featured an educational section for Leronlimab (PRO 140) as well as clear action prompts to sign-up for the trial.